Tuesday, 02 January 2024 12:17 GMT

STRONGER TOGETHER: SWITZERLAND CHAMPIONS INTERNATIONAL PARTNERSHIPS AS KEY TO ACCELERATED INNOVATION, ONCE AGAIN SWITZERLAND IS SHOWCASING ITS BIOTECH EXCELLENCE AT BIO INTERNATIONAL IN BOSTON 16-19 JUNE, 2025


(MENAFN- PR Newswire) Switzerland's biotech sector thrives on international collaboration, with 80% of Swiss biotech patents resulting from partnerships rather than competition. The country leverages its diverse talent pool and takes leadership roles in global initiatives like the 47-country Eureka network (chaired by Innosuisse) and the Access Consortium for joint regulatory approvals. This collaborative approach spans from research to market access, positioning Switzerland as a valuable global partner in solving health care challenges.

In short: "Switzerland's collaborative model offers a compelling counterproposal to 'me first' approaches, fostering international knowledge exchange to become stronger, faster and smarter together", says Michael Altorfer CEO, Swiss Biotech Association.

Switzerland Global Enterprise with its partner Swissnex in Boston and New York will be hosting a Swiss "Wine and Cheese" reception on Tuesday June 17th from 5pm to 6:30pm at the Swiss Pavilion, booth #2345.

  • Alithea Genomics

Global leader in scalable transcriptomics solutions for screening applications.

  • Altamira Therapeutics AG

Developing and supplying peptide-based nanoparticle technologies for efficient RNA delivery to extrahepatic tissues (xPhoreTM platform).

  • BioAlps Association

Acts as a life sciences cluster promoting networking and collaboration in the BioAlps community.

  • Bioengineering AG

Provides solutions in bioprocess engineering, ranging from development to production scale.

  • Biopôle SA

Operates a life sciences campus that supports innovation and development in the healthcare and biotech sectors.

  • Bioscibex

Providing cutting-edge bioreactor technologies that simplify and automate cell-based therapies.

  • BioVersys AG

Promotes Switzerland as a prime location for business and investment.

  • CDR-Life AG

Developing highly specific antibody therapeutics to target intracellular proteins presented on the major histocompatibility complex (MHC).

  • EM Microelectronic

Semiconductor manufacturer specialized in the design and production of ultra-low power, low voltage integrated circuits (IC) for battery-operated and field-powered applications.

  • Enantios AG

Utilizes cutting edge technology to analyze chiral molecules and biologics.

  • EPIC Suisse Property Management GmbH

Offers comprehensive property management services across Switzerland.

  • Ibex Therapeutics SA

Developing a patented oral topical therapy to cure and prevent oral mucositis and oral candidiasis.

  • InSphero AG

Develops and produces 3D microtissues for drug discovery and toxicity testing.

  • KPMG

Offers audit, tax, and advisory services to help organizations.

  • Limula SA

They provide a unique platform technology that enable manufacturing of clinical-grade cell products at scale, through automation and standardization.

  • Molecular Partners AG

Develops a new class of custom-built protein therapeutics known as DARPin® molecules.

  • Ninsun Biotech

Revolutionizing the marking of cancer stem cells by offering a specific biomarker for several cancers, including lung, breast and colon

  • Novavax

Proven vaccine technology, focused on developing R&D assets and establishing partnerships to leverage the value of the technology to help protect health.

  • NXI Therapeutics AG

Developing selective immunomodulators, which regulate T cell immune responses that play a key role in graft rejection and autoimmunity, while leaving the protective responses against infections and vaccination intact.

  • ObelysQ SA

Quality assurance consulting firm offering tailored solutions to the pharma industry aiming at enhancing compliance and improving processes in the execution of clinical trials.

  • OM Pharma

Engages in the research, development, and marketing of medicines in respiratory and vascular diseases.

  • PDC Therapeutics

Focuses on developing precision drugs for the treatment of severe and rare diseases.

  • Perseo Pharma AG

Breaking new ground in the treatment of metabolic diseases

  • Polaroid Therapeutics

Proprietary technology represents a significant advancement in antimicrobial therapies, setting a new standard in the industry.

  • Superlab Suisse AG

Provides high-tech laboratory services and research facilities for life sciences companies.

  • Tigermed Swiss SA

Offers clinical trial management and pharmaceutical consulting services.

  • Venture Valuation Inc.

Specializes in the assessment and valuation of growth companies in the life sciences and technology sectors.

  • Cellvie

Dedicated to advancing mitochondrial transplantation therapy to treat acute and chronic degenerative diseases.

  • FluoSphera

Provides high-throughput screening services using innovative fluorescence-based technologies.

  • Nagi Bioscience

Develops the first Organism-on-Chip technology for automated and ethical testing of drugs and chemicals.

  • REM Analytics SA

Specializes in microbiome analytics and solutions for healthcare and agricultural applications.

  • Synendos Therapeutics AG

Focuses on the development of breakthrough therapies for the treatment of central nervous system disorders.

  • Vandria

Offers digital solutions to enhance the efficiency and effectiveness of healthcare and medical management.

  • Alpha Onco

Engages in the development of innovative oncology treatments.

  • BioArk

Provides infrastructure and support for startups and established companies in the life sciences sector.

  • Ceidos SA

Specializes in virtual reality solutions, primarily for therapeutic and rehabilitation applications.

  • Excellgene

Produces biopharmaceuticals using advanced cell line engineering and protein production technologies.

  • Immunskills

Offers workshops and training in immunotherapy and biological production.

  • Novochizol SA

Develops chitosan-based formulations to enhance the delivery of biopharmaceuticals.

  • Orio Therapeutics

Specializes in developing therapies for respiratory diseases.

  • SETI / Canton VS

Supports economic development in Valais, particularly in the sectors of technology, education, and innovation.

  • Stämm Biotech

Works on bioprocesses that utilize human stem cells for regenerative medicine.

  • Swiss Biotech Center

Provides laboratory services, R&D, and consulting to foster innovation in biotechnology.

  • ten23 health Valais Ltd .

Offers services in drug development and manufacturing, with a focus on sustainable practices.

  • Ymmunobio AG

Ymmunobio AG is a preclinical stage biotechnology company developing a novel class of immune oncology therapeutic antibodies.

The SWISS BIOTECH companies will be available for media and partner interviews the entire week.

Media Contacts

Partnerships & Business Development

Lisette Müry

Karine J. Wittmer

E: [email protected]

E. [email protected]



Trade Fairs

Foreign Direct Investment

Export Promotion & Global Network

Trade Commissioner

Bettina Thomas

Sean Powers

E: [email protected]

E: class="prnews_a" href="/cdn-cgi/l/email-protection#e8bb8d8986c5a5818b80898d84c6b8879f8d9a9ba88d8c89c4898c858186c68b80" rel="nofollow" Powers@eda,admi

About Switzerland Global Enterprise
Switzerland Global Enterprise (S-GE) is the official Swiss organization for export and investment promotion with around 200 employees at locations throughout Switzerland and overseas. S-GE supports Swiss SMEs in their international business and helps innovative foreign companies to settle in Switzerland. In doing so, we rely on a unique network of national and international partners. This allows us to create added value for our customers and prosperity for Switzerland. As a non-profit organization, we provide a public service for our clients on behalf of the Swiss Confederation (State Secretariat for Economic Affairs SECO) and the cantons. We operate our 27 offices, the so-called Swiss Business Hubs, and Trade Points, in 31 countries jointly with the Federal Department of Foreign Affairs (FDFA). Thanks to our global network of partners, we also support our customers in many other countries.

SOURCE Swiss Business Hub USA

MENAFN11062025003732001241ID1109661342


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

Search